There is a Dr. Joseph Kim working on an Ebola vaccine. Inovio is moving its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc.
Dr. J. Joseph Kim , President and CEO, said, "Inovio's SynCon® DNA-based immunotherapy and vaccine technology offers an advantageous set of characteristics and capabilities to generate and direct powerful immune responses against a target disease. There are no proven agents to check the spread of Ebola, which is now becoming a health threat of global concern. We are therefore taking the steps with our collaborator to establish the safety and immunogenicity of our Ebola vaccine in humans and be in a position to further advance these agents to help fight this challenging disease."
No comments:
Post a Comment